Joel Embiid: Everything you need to know

Joel Embiid

#21 C

Philadelphia 76ers

Status

GTD - Ankle Expected Return: 2026-05-06

STATS

Career Averages

PTS

REB

AST

BLK

STL

27.6

10.8

3.7

1.6

0.9

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	TD3	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2025-26	38	38	31.6	26.9	7.7	3.9	1.2	0.6	2.9	10	1	1.4	4.2	33.3%	7.6	14.2	53.5%	9.0	18.3	48.9%	7.5	8.8	85.4%	2.0	5.7	2.2	1.4	+155	60.5%
2024-25	19	19	30.2	23.8	8.2	4.5	0.9	0.7	3.3	7	1	1.2	4.1	29.9%	6.2	12.5	49.2%	7.4	16.6	44.4%	7.8	8.9	88.2%	1.9	6.3	2.2	1.4	-57	58.0%
2023-24	39	39	33.6	34.7	11.0	5.6	1.7	1.2	3.8	30	2	1.4	3.6	38.8%	10.2	18.3	55.6%	11.5	21.8	52.9%	10.2	11.6	88.3%	2.4	8.6	2.9	1.5	+267	64.4%
2022-23	66	66	34.6	33.1	10.2	4.2	1.7	1.0	3.4	39	1	1.0	3.0	33.0%	10.0	17.1	58.7%	11.0	20.1	54.8%	10.0	11.7	85.7%	1.7	8.4	3.1	1.2	+424	65.5%
2021-22	68	68	33.8	30.6	11.7	4.2	1.5	1.1	3.1	46	2	1.4	3.7	37.1%	8.4	15.9	52.9%	9.8	19.6	49.9%	9.6	11.8	81.4%	2.1	9.6	2.7	1.3	+367	61.6%
2020-21	51	51	31.1	28.5	10.6	2.8	1.4	1.0	3.1	31	0	1.1	3.0	37.7%	7.9	14.6	54.1%	9.0	17.6	51.3%	9.2	10.7	85.9%	2.2	8.4	2.4	0.9	+405	63.6%
2019-20	51	51	29.5	23.0	11.6	3.0	1.3	0.9	3.1	37	0	1.1	3.4	33.1%	6.4	12.3	51.7%	7.5	15.7	47.7%	6.9	8.5	80.7%	2.8	8.9	3.4	1.0	+163	59.0%
2018-19	64	64	33.7	27.5	13.6	3.7	1.9	0.7	3.5	58	2	1.2	4.1	30.0%	7.8	14.6	53.5%	9.1	18.7	48.4%	8.2	10.1	80.4%	2.5	11.1	3.3	1.0	+371	59.3%
2017-18	63	63	30.4	22.9	11.0	3.2	1.8	0.6	3.7	38	0	1.0	3.4	30.8%	7.0	13.4	52.7%	8.1	16.8	48.3%	5.7	7.4	76.9%	2.3	8.7	3.3	0.9	+484	57.3%
2016-17	31	31	25.4	20.2	7.8	2.1	2.5	0.9	3.8	0	0	1.2	3.2	36.7%	5.3	10.7	49.5%	6.5	13.8	46.6%	6.2	7.9	78.3%	2.0	5.9	3.6	0.6	+0	58.4%
Career	490	490	31.9	27.6	10.8	3.7	1.6	0.9	3.4	296	9	1.2	3.5	33.9%	7.9	14.7	53.9%	9.1	18.2	50.0%	8.3	9.9	83.0%	2.2	8.6	3.0	1.1	+2579	61.3%

Career Averages

PTS

REB

AST

BLK

STL

24.9

10.6

3.3

1.6

0.8

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	TD3	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2025-26	5	5	34.2	25.2	8.0	5.8	0.6	0.4	1.8	3	0	0.6	4.4	13.6%	7.8	15.4	50.6%	8.4	19.8	42.4%	7.8	9.2	84.8%	1.2	6.8	2.2	3.2	-18	52.8%
2023-24	6	6	41.3	33.0	10.8	5.7	1.5	1.2	4.2	4	1	2.2	6.5	33.3%	7.7	15.7	48.9%	9.8	22.2	44.4%	11.2	13.0	85.9%	3.2	7.7	3.3	1.4	+46	59.2%
2022-23	9	9	37.3	23.7	9.8	2.7	2.8	0.7	3.9	5	0	0.6	3.1	17.9%	6.8	13.9	48.8%	7.3	17.0	43.1%	8.4	9.3	90.5%	1.8	8.0	3.0	0.7	-6	56.1%
2021-22	10	10	38.5	23.6	10.7	2.1	0.8	0.4	3.2	8	0	0.7	3.3	21.2%	7.1	12.8	55.5%	7.8	16.1	48.4%	7.3	8.9	82.0%	2.1	8.6	3.4	0.7	+28	59.0%
2020-21	11	11	32.5	28.1	10.5	3.4	1.5	1.0	3.8	5	0	1.5	3.7	39.0%	7.7	14.2	54.5%	9.2	17.9	51.3%	8.3	9.9	83.5%	1.5	9.1	3.0	0.9	+121	63.1%
2019-20	4	4	36.3	30.0	12.3	1.3	1.3	1.5	3.8	4	0	1.0	4.0	25.0%	7.5	14.5	51.7%	8.5	18.5	45.9%	12.0	14.8	81.4%	2.8	9.5	4.5	0.3	-53	60.0%
2018-19	11	11	30.4	20.2	10.5	3.4	2.3	0.7	3.6	7	0	1.1	3.5	30.8%	5.1	10.9	46.7%	6.2	14.5	42.8%	6.7	8.2	82.2%	1.9	8.5	3.1	0.9	+143	55.9%
2017-18	8	8	34.8	21.4	12.6	3.0	1.8	0.9	3.6	7	0	1.0	3.6	27.6%	6.5	13.6	47.7%	7.5	17.3	43.5%	5.4	7.6	70.5%	2.9	9.8	3.9	0.8	+43	51.9%
Career	64	64	35.2	24.9	10.6	3.3	1.6	0.8	3.5	43	1	1.1	3.9	27.5%	6.9	13.5	50.7%	7.9	17.4	45.6%	8.0	9.6	83.0%	2.1	8.6	3.3	0.9	+304	57.6%

Regular Season
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
4/6	SAS	L 115-102	39	34	12	1	4	0	4	6	2	33.3%	13	6	46.2%	19	8	42.1%	19	16	84.2%	5	7	0.3	-7	3	40	62.1%
4/3	MIN	W 115-103	34	19	13	7	3	0	1	6	1	16.7%	11	5	45.5%	17	6	35.3%	7	6	85.7%	2	11	7.0	+15	3	29	47.3%
3/30	MIA	L 119-109	34	26	7	3	1	0	3	6	2	33.3%	19	8	42.1%	25	10	40.0%	5	4	80.0%	1	6	1.0	-18	4	15	47.8%
3/28	CHA	W 118-114	35	29	6	2	2	0	0	6	3	50.0%	13	5	38.5%	19	8	42.1%	13	10	76.9%	0	6	0.0	+5	0	33	58.7%
3/25	CHI	W 157-137	28	35	6	7	1	0	3	3	3	100.0%	14	9	64.3%	17	12	70.6%	9	8	88.9%	0	6	2.3	+33	2	44	83.5%
2/26	MIA	W 124-117	31	26	11	4	0	1	2	6	2	33.3%	14	6	42.9%	20	8	40.0%	9	8	88.9%	1	10	2.0	+0	1	32	54.3%
2/24	IND	W 135-114	26	27	6	5	1	0	4	4	1	25.0%	13	10	76.9%	17	11	64.7%	5	4	80.0%	1	5	1.3	-1	2	30	70.3%
2/7	PHX	W 109-103	33	33	9	3	1	0	2	7	4	57.1%	12	5	41.7%	19	9	47.4%	13	11	84.6%	1	8	1.5	-10	3	35	66.7%
2/5	LAL	L 119-115	38	35	7	7	2	1	3	2	1	50.0%	17	12	70.6%	19	13	68.4%	8	8	100.0%	1	6	2.3	+7	2	49	77.7%
2/2	LAC	W 128-113	32	24	5	3	0	1	1	2	1	50.0%	17	7	41.2%	19	8	42.1%	7	7	100.0%	0	5	3.0	+2	4	22	54.3%
1/31	NOP	W 124-114	39	40	11	4	2	1	5	5	3	60.0%	22	10	45.5%	27	13	48.1%	14	11	78.6%	4	7	0.8	+16	2	38	60.3%
1/29	SAC	W 113-111	35	37	5	8	1	1	2	2	1	50.0%	19	12	63.2%	21	13	61.9%	13	10	76.9%	0	5	4.0	+9	3	44	69.2%
1/27	MIL	W 139-122	29	29	9	5	0	1	2	4	1	25.0%	20	10	50.0%	24	11	45.8%	6	6	100.0%	6	3	2.5	+6	2	27	54.4%
1/24	NYK	L 112-109	36	38	11	5	1	0	4	5	3	60.0%	16	10	62.5%	21	13	61.9%	12	9	75.0%	3	8	1.3	-3	2	45	72.3%
1/22	HOU	W 128-122	45	32	15	10	1	1	5	3	1	33.3%	16	9	56.3%	19	10	52.6%	12	11	91.7%	3	12	2.0	+21	1	53	65.9%
1/19	IND	W 113-104	33	30	9	4	0	0	1	1	1	100.0%	16	9	56.3%	17	10	58.8%	10	9	90.0%	2	7	4.0	+3	1	38	70.1%
1/16	CLE	L 117-115	33	33	5	3	1	0	1	3	2	66.7%	19	8	42.1%	22	10	45.5%	12	11	91.7%	3	2	3.0	+9	0	34	60.5%
1/14	CLE	L 133-107	24	20	4	3	1	1	6	5	2	40.0%	9	5	55.6%	14	7	50.0%	4	4	100.0%	2	2	0.5	-18	0	17	63.5%
1/12	TOR	W 115-102	35	27	8	4	0	2	7	6	1	16.7%	11	8	72.7%	17	9	52.9%	8	8	100.0%	2	6	0.6	+12	1	28	65.8%
1/9	ORL	W 103-91	31	22	9	3	1	1	4	3	0	0.0%	14	7	50.0%	17	7	41.2%	9	8	88.9%	3	6	0.8	+4	2	23	52.5%
1/7	WAS	W 131-110	25	28	7	2	2	0	2	2	1	50.0%	12	9	75.0%	14	10	71.4%	8	7	87.5%	0	7	1.0	+27	3	33	79.9%
1/5	DEN	L 125-124	40	32	10	2	1	0	6	4	1	25.0%	18	12	66.7%	22	13	59.1%	5	5	100.0%	6	4	0.3	+8	2	32	66.1%
1/3	NYK	W 130-119	33	26	10	5	0	0	3	1	0	0.0%	14	9	64.3%	15	9	60.0%	12	8	66.7%	2	8	1.7	+9	4	31	64.1%
1/1	DAL	W 123-108	35	22	4	6	1	0	2	3	0	0.0%	15	9	60.0%	18	9	50.0%	5	4	80.0%	0	4	3.0	+9	1	25	54.5%
12/30	MEM	W 139-136	38	34	10	8	2	1	4	6	1	16.7%	22	10	45.5%	28	11	39.3%	12	11	91.7%	5	5	2.0	-5	5	34	51.1%
12/26	CHI	L 109-102	32	31	5	1	1	0	2	4	2	50.0%	15	8	53.3%	19	10	52.6%	9	9	100.0%	1	4	0.5	+2	2	29	67.5%
12/23	BKN	L 114-106	31	27	6	4	2	0	3	1	1	100.0%	12	7	58.3%	13	8	61.5%	12	10	83.3%	1	5	1.3	+1	5	33	73.9%
12/14	ATL	L 120-117	30	22	14	1	2	1	3	3	1	33.3%	17	7	41.2%	20	8	40.0%	6	5	83.3%	6	8	0.3	-8	2	27	48.6%
12/12	IND	W 115-105	31	39	9	3	0	1	3	8	2	25.0%	15	10	66.7%	23	12	52.2%	18	13	72.2%	2	7	1.0	+16	3	38	63.1%
12/7	LAL	L 112-108	30	16	7	2	1	1	0	6	0	0.0%	15	4	26.7%	21	4	19.0%	8	8	100.0%	2	5	0.0	+11	1	12	32.6%
12/4	GSW	W 99-98	25	12	6	3	1	0	3	5	0	0.0%	8	5	62.5%	13	5	38.5%	2	2	100.0%	0	6	1.0	+2	1	11	43.2%
11/30	ATL	L 142-134	30	18	4	2	1	1	2	3	0	0.0%	11	6	54.5%	14	6	42.9%	8	6	75.0%	1	3	1.0	-11	2	16	51.4%
11/8	TOR	W 130-120	25	29	6	4	1	0	2	4	1	25.0%	12	9	75.0%	16	10	62.5%	9	8	88.9%	2	4	2.0	+15	3	35	72.6%
11/4	CHI	L 113-111	25	20	6	2	4	3	3	6	1	16.7%	15	6	40.0%	21	7	33.3%	6	5	83.3%	2	4	0.7	+1	2	17	42.3%
10/31	BOS	L 109-108	25	20	6	3	2	0	4	2	1	50.0%	11	5	45.5%	13	6	46.2%	7	7	100.0%	1	5	0.8	+2	2	24	62.2%
10/28	WAS	W 139-134	23	25	7	5	1	0	3	6	3	50.0%	11	6	54.5%	17	9	52.9%	6	4	66.7%	3	4	1.7	+9	4	24	63.6%
10/25	CHA	W 125-121	20	20	2	4	0	2	4	6	3	50.0%	5	4	80.0%	11	7	63.6%	5	3	60.0%	0	2	1.0	-2	0	23	75.8%
10/22	BOS	W 117-116	20	4	6	2	1	0	0	4	0	0.0%	5	1	20.0%	9	1	11.1%	2	2	100.0%	1	5	0.0	-16	2	4	20.2%
Regular Season Totals			31.6	26.9	7.7	3.9	1.2	0.6	2.9	4.2	1.4	33.3%	14.2	7.6	53.5%	18.3	9.0	48.9%	8.8	7.5	85.4%	2.0	5.7	1.4	+155	2.2	32.8	60.5%

Postseason
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
5/4	NYK	L 137-98	24	14	4	1	0	0	1	2	0	0.0%	9	3	33.3%	11	3	27.3%	9	8	88.9%	0	4	1.0	-24	1	14	46.8%
5/2	BOS	W 109-100	39	34	12	6	1	0	1	4	1	25.0%	22	11	50.0%	26	12	46.2%	11	9	81.8%	2	10	6.0	+11	2	45	55.1%
4/30	BOS	W 106-93	34	19	10	8	0	1	1	5	1	20.0%	13	5	38.5%	18	6	33.3%	7	6	85.7%	1	9	8.0	+7	2	26	45.1%
4/28	BOS	W 113-97	38	33	4	8	1	0	3	5	0	0.0%	18	12	66.7%	23	12	52.2%	10	9	90.0%	1	3	2.7	+13	4	32	60.2%
4/26	BOS	L 128-96	34	26	10	6	1	1	3	6	1	16.7%	15	8	53.3%	21	9	42.9%	9	7	77.8%	2	8	2.0	-25	2	33	52.1%
Postseason Totals			34.2	25.2	8.0	5.8	0.6	0.4	1.8	4.4	0.6	13.6%	15.4	7.8	50.6%	19.8	8.4	42.4%	9.2	7.8	84.8%	1.2	6.8	3.2	-18	2.2	33.2	52.8%

Joel Embiid: Breaking News

Embiid (ankle) is probable for Game 2 of the Eastern Conference Semifinals against the Knicks on Wednesday, per Adam Aaronson of PhillyVoice.com. Embiid is dealing with a right ankle sprain, though the issue isn't expected to be severe enough to stop him from playing Wednesday. Over five appearances during the 2026 postseason to this point, the star big man has averaged 25.2 points, 8.0 rebounds and 5.8 assists in 34.2 minutes per game.

Embiid finished Monday's 137-98 loss to New York in Game 1 of the Eastern Conference Semifinals with 14 points (3-11 FG, 0-2 3Pt, 8-9 FT), four rebounds and one assist across 25 minutes. Embiid had a productive night at the charity stripe but struggled mightily from the field. After posting back-to-back double-doubles to close out the first round against Boston, the star big man couldn't carry that momentum into this one. While he still finished as Philadelphia's second-leading scorer, his struggles from beyond the arc continued -- he is shooting just 13.6 percent from deep in five postseason games. Embiid and the Sixers will look to steal a game at Madison Square Garden in Game 2 on Wednesday.

Embiid (abdomen) is available and starting Game 1 of the Eastern Conference Semifinals against the Knicks on Monday. Embiid was tagged as probable leading up to Game 1, and he's since been given the green light to take the court. He didn't appear to be on any type of minutes restriction in the first round against Boston, as he averaged 28.0 points, 9.0 rebounds and 7.0 assists across 36.5 minutes per game in four appearances.